Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1973 6
1974 10
1975 15
1976 16
1977 9
1978 37
1979 88
1980 67
1981 133
1982 151
1983 175
1984 166
1985 232
1986 245
1987 283
1988 323
1989 360
1990 382
1991 345
1992 364
1993 381
1994 349
1995 342
1996 398
1997 347
1998 344
1999 313
2000 334
2001 321
2002 331
2003 348
2004 370
2005 386
2006 440
2007 419
2008 446
2009 478
2010 557
2011 621
2012 675
2013 700
2014 790
2015 805
2016 853
2017 868
2018 811
2019 404
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

15,489 results
Results by year
Filters applied: . Clear all
Page 1
Ferroptosis: A Novel Anti-tumor Action for Cisplatin.
Guo J, et al. Cancer Res Treat 2018. PMID 28494534 Free PMC article.
RESULTS: Among five chemotherapeutic drugs screened in this study, cisplatin was found to be an inducer for both ferroptosis and apoptosis in A549 and HCT116 cells. The depletion of reduced glutathione caused by cisplatin and the inactivation of glutathione peroxidase played the vital role in the underlying mechanism. ...
RESULTS: Among five chemotherapeutic drugs screened in this study, cisplatin was found to be an inducer for both ferroptosis and apop …
Cisplatin.
Trimmer EE and Essigmann JM. Essays Biochem 1999 - Review. PMID 10730196
Cisplatin is a widely used anti-cancer drug that is exceptionally effective against testicular cancer. trans-DDP, the geometric isomer of cisplatin, is ineffective as a chemotherapeutic agent. ...Both intrinsic and drug-induced resistance often limit the success of cisplatin; several specific mechanisms of cisplatin resistance have been identified....
Cisplatin is a widely used anti-cancer drug that is exceptionally effective against testicular cancer. trans-DDP, the geometric isome
Cisplatin based therapy: the role of the mitogen activated protein kinase signaling pathway.
Achkar IW, et al. J Transl Med 2018 - Review. PMID 29642900 Free PMC article.
A Combination of cisplatin with other drugs is an approach to overcome drug resistance and reduce toxicity. The combination therapy also results in increased sensitivity of cisplatin towards cancer cells. ...This review article demonstrates the role of MAPK pathway in cisplatin based therapy, illustrates different combination therapy involving cisplatin and also shows the importance of targeting MAPK family, particularly RSK, to achieve increased anticancer effect and overcome drug resistance when combined with cisplatin....
A Combination of cisplatin with other drugs is an approach to overcome drug resistance and reduce toxicity. The combination therapy a …
Cisplatin.
[No authors listed] Rep Carcinog 2004. PMID 21089836 Free article.
Cisplatin.
[No authors listed] Lancet 1982. PMID 6120354
Peptide-Based Autophagic Gene and Cisplatin Co-delivery Systems Enable Improved Chemotherapy Resistance.
Lin YX, et al. Nano Lett 2019. PMID 30924343
Cisplatin-based chemotherapy is a widely used first-line strategy for numerous cancers. However, drug resistances are often inevitable accompanied by the long-term use of cisplatin in vivo, significantly hampering its therapeutic efficacy and clinical outcomes. Among others, autophagy induction is one of the most common causes of tumor resistance to cisplatin. Herein, a self-assembled nanoprodrug platform was developed with the synergistic effect of cisplatin and RNAi to fight against cisplatin-resistant lung cancer. ...
Cisplatin-based chemotherapy is a widely used first-line strategy for numerous cancers. However, drug resistances are often inevitabl
Cisplatin.
Reed E. Cancer Chemother Biol Response Modif 1990 - Review. PMID 2223411
Impact of Methadone on Cisplatin Treatment of Bladder Cancer Cells.
Michalska M, et al. Anticancer Res 2018. PMID 29491061
BACKGROUND: Cisplatin-based chemotherapy is the treatment of choice for advanced bladder cancer. Since many tumor cells show inherent or acquired cisplatin resistance, research is needed to improve the therapeutic efficacy. ...RESULTS: Methadone was shown to enhance the cytotoxic effects of cisplatin on T24 cells based on the induction of apoptosis. ...
BACKGROUND: Cisplatin-based chemotherapy is the treatment of choice for advanced bladder cancer. Since many tumor cells show inherent …
Cisplatin.
Reed E. Cancer Chemother Biol Response Modif 1992 - Review. PMID 1389927
Nutritional shortage augments cisplatin-effects on murine melanoma cells.
Antunes F, et al. Chem Biol Interact 2018. PMID 29273566 Free article.
Our results showed that nutritional deprivation augmented cell death induced by cisplatin in melanoma cells, especially at the metastatic subtype, with slight effects on melanocytes. ...In conclusion, nutritional shortage in combination with chemotherapeutic drugs as cisplatin can be a valuable new therapeutic strategy to overcome melanoma resistance....
Our results showed that nutritional deprivation augmented cell death induced by cisplatin in melanoma cells, especially at the metast …
15,489 results
Jump to page
Feedback